Prasugrel (marketing name Effient in the US, Efient in the EU and Prasita in India) is a novel platelet inhibitor developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). Prasugrel was approved for use in Europe in February 2009, and is currently available in the UK. On July 10, 2009, the US Food and Drug Administration approved the use of prasugrel for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.
Padi, Pratap Reddy; Peri, Seetha Rama Sarma; Ganta, Madhusudhan Reddy; Polavarapu, Srinivas; Cherukupally, Praveen; Ireni, Babu; Padamata, Shailaja; Jonnada, Krishna; Vinigari, Krishna; Nerella, Kavitha. A process for preparing prasugrel and its salts and polymorphs. Assignee Dr. Reddy's Laboratories Ltd., India; Dr. Reddy's Laboratories, Inc. WO 2009062044. (2009).
Reddy, Manne Satyanarayana; Eswaraiah, Sajja; Reddy, Ghojala Venkat. Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts. Assignee MSN Laboratories Limited, India. IN 292121. (2018).
Ou, Wenhua; Yi, Weiyin; Liu, Feng; Pan, Xianhua; Peng, Xijiang. An improvement to the preparation of prasugrel hydrochloride. Journal of Chemical Research. Volume 37. Issue 6. Pages 369-371. 2013.
Rao, A. v. v. Srinivas; Jaware, Jalindar; Goud, Srinivas; Bijukumar, Gopinathan Pillai; Nadkarni, Sunil Sadanand. Process for the preparation of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine. Assignee Torrent Pharmaceuticals Ltd., India. WO 2009122440. (2009).
Ahmed, Khan Mubeen; Sanikommu, Srinivas Reddy; Antyakula Pydi, Bhaskar Rao; Sanganabhatla, Shankar. Preparation of prasugrel and its hydrochloride salt and crystal forms. Assignee Glenmark Generics Limited, India. WO 2010070677. (2010).
Stepankova, Hana; Hajicek, Josef. Process for the manufacturing of 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (prasugrel). Assignee Zentiva A.S., Czech Rep. WO 2009006859. (2009).
Satyanarayana Reddy, Manne; Thirumalai Rajan, Srinivasan; Eswaraiah, Sajja; Reddy, Karamala Rama Subba; Kondal Reddy, Bairy; Reddy, Ghojala Venkat. Novel and improved processes for the preparation of prasugrel, its intermediates and pharmaceutically acceptable salts. Assignee MSN Laboratories Limited, India. WO 2011042918. (2011).
Zhao, Zhiquan; Bai, Wenqin. Preparation of prasugrel and its salts as platelet aggregation inhibitors. Assignee Lunan Pharmaceutical Group Corporation, Peop. Rep. China. CN 101177430. (2008).
Ou, Wenhua; Yi, Weiyin; Liu, Feng; Pan, Xianhua; Peng, Xijiang. An improvement to the preparation of prasugrel hydrochloride. Journal of Chemical Research. Volume 37. Issue 6. Pages 369-371. 2013.
Thijs, Lambertus; Zhu, Jie; Overeem, Arjanne; Keltjens, Rolf. A process for making prasugrel. Assignee Synthon BV, Neth. WO 2011110219. (2011).
